跳至主要内容

Chemical synthesized peptide drugs

 

Company Profile:

Medicilon's peptide synthesis research team is closely focused on the topic of peptide drug research and is committed to solving the core problems that limit the development and application of peptide drugs. To improve the downstream peptide drug signal transduction pathways and mechanisms of action to improve the system. Through multi-disciplinary cooperation and intersections in chemistry, biology, medicine, and pharmacy, outstanding achievements have been made in basic and applied research.

Medicilon can undertake the synthesis of special reagents, intermediates and molecular fragments, preparation of standard products, synthesis design and preparation of impurities or metabolites, synthesis of stable isotope internal standards and synthesis of tritiated compounds.

Peptide-Synthesis-Service
Chemical synthesized peptide drugs

Peptide Synthesis Service:

  • Standard chemical peptide synthesis

  • Peptide modification

  • Peptide library

  • Recombinant polypeptide expression

  • Pharmaceutical peptide synthesis

  • Structural modification

  • Nuclear magnetic structure analysis

  • function test

Peptide custom synthesis, peptide solid phase synthesis, synthetic peptide, biosynthetic peptide, genetic chemical synthesis

The development of peptide and protein drugs by chemical synthesis methods has become an effective method widely adopted. Through liquid phase synthesis, solid phase synthesis, solid/liquid synthesis combination and fragment connection, etc., many peptide and protein drugs have been successfully developed.

Peptide synthesis is the process of synthesizing polypeptides in organic chemistry. Polypeptides are organic compounds that are connected by multiple amino acids through peptide bonds. In biology, the process of synthesizing long polypeptides (proteins) is called protein biosynthesis. The synthesis of peptides is a process in which carboxyl groups (or C-terminus) and amine groups (or N-terminus) are paired with each other. Due to the possibility of unexpected reactions, protecting groups are necessary. The process of chemical peptide synthesis begins at the C-terminus and ends at the N-terminus of the peptide, whereas protein biosynthesis starts from the N-terminus and ends at the C-terminus of the polypeptide.

Contact us: 021-58591500

Email: marketing@medicilon.com

Website: www.medicilon.com

Related Articles:

Chemistry service

Chemical FTE Service

Medicilon Drug Impurity Analysis Service

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati